16 October 2023
16 October 2023
This ten-storey, 373-bed, 702,000ft² facility will be able to accommodate 90,000 annual visits.
Mass General Cancer Center is claimed to be the first in the world globally to provide proton therapy.
Slated for completion in 2025, this project aims to provide advanced emergency care to both adults and children.
It aims to support the training, recruitment, and retention of healthcare professionals in the north-west region.
The Cockburn Medicare Urgent Care Clinic aims to alleviate the pressure on Fiona Stanley Hospital.
The PFF Care Center Network now includes 81 CCN sites and seven Clinical Associates across 39 US states.
The PoC aims to assist staff and ensure patients are in the right beds at the right times.
The company plans to use the proceeds to speed up the launch of OdySight in France and across the globe.
Join us on November 1st as Cynthia Bheling, Zobair Younossi, Rohit Loompa, and Vipul Jairath provide an overview of the drug development landscape.
With only a few approved drugs currently available to treat DN by means other than regulation of blood pressure, innovator products that can treat by targeting other factors such as treatment of dyslipidemia, hypertension, or angiotensin inhibition, among others, is a key area of R&D in the DN space and is likely to pave the way for novel therapies in the near future. However, the treatment landscape is expected to remain unchanged due to limited availability of products in the late-stage pipeline currently.
Give your business an edge with our leading industry insights.
